Suspected clopidogrel-associated hepatitis in a cat

Area of Science:

• Veterinary Medicine
• Pharmacology
• Hepatology

Background:

• Clopidogrel is commonly used to treat feline cardiomyopathies.
• The safety and adverse effects of clopidogrel in cats are not well-documented.
• Limited studies exist on clopidogrel's adverse effects in feline patients.

Observation:

• A 6-year-old castrated male cat with hypertrophic cardiomyopathy phenotype was treated with clopidogrel.
• The cat developed signs of acute hepatitis after 5 weeks of treatment.
• This case highlights a potential adverse reaction to clopidogrel in cats.

Findings:

• Acute hepatitis is a rare but potential adverse effect of clopidogrel in cats.
• Hepatotoxicity should be considered in feline patients experiencing clinical deterioration while on clopidogrel therapy.
• This case contributes to the limited literature on clopidogrel's safety profile in veterinary medicine.

Implications:

• Veterinarians should be aware of the potential for clopidogrel-induced hepatotoxicity in cats.
• Monitoring liver function in cats receiving clopidogrel is recommended.
• Further research is needed to fully understand the risks and benefits of clopidogrel in feline patients.